IMMUNE CONTROL OF CAE LENTIVIRUS

CAE 慢病毒的免疫控制

基本信息

  • 批准号:
    2083460
  • 负责人:
  • 金额:
    $ 10.46万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1995
  • 资助国家:
    美国
  • 起止时间:
    1995-09-30 至 1998-08-31
  • 项目状态:
    已结题

项目摘要

This proposal tests the hypothesis that a focused cell mediated immune response to immunization with a purified lentiviral surface (SU) glycoprotein will control virus replication and disease following challenge infection with homologous and heterologous virus. The research plan is to focus antigen specific T helper (Th) 1 lymphocyte responses by enhancing in vivo production of gamma interferon (IFN gamma) at the time of immunization. A vaccinia virus vector and plasmid DNA expressing IFN gamma cDNA will be evaluated to enhance IFN gamma production in vivo. This plan is based on well documented studies in mice demonstrating that crossregulatory cytokines specify the differentiation of Th1 and Th2 lymphocyte subsets from a common precursor at the time of antigen presentation, overriding the effects of other variables such as antigen dosage and MHC class II genotype. The lentiviral system to be studied is caprine arthritis-encephalitis virus (CAEV) in Saanen goats. The utility of the CAEV model for evaluating the role of Th1 responses to SU in immune control of lentivirus replication and disease is enhanced by preliminary data supporting the following: (1) CAEV infected goats have at least two populations of SU responsive CD4+ T lymphocytes with dichotomous antigen specific proliferative responses and patterns of IFNgamma gene expression analogous to Th1 and Th2 cells. (2) Dominance of CAEV SU responsive Th1 cells is specifically associated with restricted virus load and lack of disease progression. (3) The extent of CAEV replication and disease may be determined by differential activation of SU responsive Th1 or Th2 lymphocyte subsets at or near the time of infection. Thus, the anticipated results of this research will demonstrate the feasibility of using recombinant cytokines to focus antigen specific Th lymphocyte pathways in outbred species and provide an opportunity to directly examine the role of Th1 responses in immune control of a persistent lentivirus infection.
这一提议验证了聚焦细胞介导免疫的假设

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

WILLIAM P CHEEVERS其他文献

WILLIAM P CHEEVERS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('WILLIAM P CHEEVERS', 18)}}的其他基金

CYTOKINE MODULATION OF LENTIVIRAL DNA VACCINES
慢病毒 DNA 疫苗的细胞因子调节
  • 批准号:
    2878029
  • 财政年份:
    1997
  • 资助金额:
    $ 10.46万
  • 项目类别:
CYTOKINE MODULATION OF LENTIVIRAL DNA VACCINES
慢病毒 DNA 疫苗的细胞因子调节
  • 批准号:
    2555244
  • 财政年份:
    1997
  • 资助金额:
    $ 10.46万
  • 项目类别:
IMMUNE CONTROL OF CAE LENTIVIRUS
CAE 慢病毒的免疫控制
  • 批准号:
    2517499
  • 财政年份:
    1995
  • 资助金额:
    $ 10.46万
  • 项目类别:
IMMUNE CONTROL OF CAE LENTIVIRUS
CAE 慢病毒的免疫控制
  • 批准号:
    6632626
  • 财政年份:
    1995
  • 资助金额:
    $ 10.46万
  • 项目类别:
IMMUNE CONTROL OF CAE LENTIVIRUS
CAE 慢病毒的免疫控制
  • 批准号:
    6408661
  • 财政年份:
    1995
  • 资助金额:
    $ 10.46万
  • 项目类别:
IMMUNE CONTROL OF CAE LENTIVIRUS
CAE 慢病毒的免疫控制
  • 批准号:
    6511867
  • 财政年份:
    1995
  • 资助金额:
    $ 10.46万
  • 项目类别:
IMMUNE CONTROL OF CAE LENTIVIRUS
CAE 慢病毒的免疫控制
  • 批准号:
    2083463
  • 财政年份:
    1995
  • 资助金额:
    $ 10.46万
  • 项目类别:
PATHOGENESIS OF LENTIVIRUS-INDUCED ARTHRITIS
慢病毒引起的关节炎的发病机制
  • 批准号:
    2078620
  • 财政年份:
    1992
  • 资助金额:
    $ 10.46万
  • 项目类别:
PATHOGENESIS OF RETROVIRUS INDUCED ARTHRITIS
逆转录病毒引起的关节炎的发病机制
  • 批准号:
    3155553
  • 财政年份:
    1981
  • 资助金额:
    $ 10.46万
  • 项目类别:
PATHOGENESIS OF RETROVIRUS INDUCED ARTHRITIS
逆转录病毒引起的关节炎的发病机制
  • 批准号:
    3155560
  • 财政年份:
    1981
  • 资助金额:
    $ 10.46万
  • 项目类别:

相似海外基金

Active immunization mouse model by cN1A peptides
cN1A肽主动免疫小鼠模型
  • 批准号:
    18K15370
  • 财政年份:
    2018
  • 资助金额:
    $ 10.46万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Development of an efficient oocyte collection method using active immunization against inhibin in cynomolgus monkeys.
使用食蟹猴主动免疫抑制素开发有效的卵母细胞收集方法。
  • 批准号:
    17H06766
  • 财政年份:
    2017
  • 资助金额:
    $ 10.46万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Passive and Active Immunization for Pneumocystis
肺孢子虫的被动和主动免疫
  • 批准号:
    9182862
  • 财政年份:
    2015
  • 资助金额:
    $ 10.46万
  • 项目类别:
Active Immunization for Treating Methamphetamine Abuse
治疗甲基苯丙胺滥用的主动免疫
  • 批准号:
    8136035
  • 财政年份:
    2007
  • 资助金额:
    $ 10.46万
  • 项目类别:
Active Immunization for Treating Methamphetamine Abuse
治疗甲基苯丙胺滥用的主动免疫
  • 批准号:
    7921670
  • 财政年份:
    2007
  • 资助金额:
    $ 10.46万
  • 项目类别:
Can passive or active immunization alter the course of infection with circoviral DNA?
被动或主动免疫可以改变圆环病毒 DNA 的感染过程吗?
  • 批准号:
    306844-2004
  • 财政年份:
    2007
  • 资助金额:
    $ 10.46万
  • 项目类别:
    Special Research Opportunity Program - Project
Active Immunization for Treating Methamphetamine Abuse
治疗甲基苯丙胺滥用的主动免疫
  • 批准号:
    7502083
  • 财政年份:
    2007
  • 资助金额:
    $ 10.46万
  • 项目类别:
Active Immunization for Treating Methamphetamine Abuse
治疗甲基苯丙胺滥用的主动免疫
  • 批准号:
    7341002
  • 财政年份:
    2007
  • 资助金额:
    $ 10.46万
  • 项目类别:
Active Immunization for Treating Methamphetamine Abuse
治疗甲基苯丙胺滥用的主动免疫
  • 批准号:
    7679096
  • 财政年份:
    2007
  • 资助金额:
    $ 10.46万
  • 项目类别:
Passive-Active Immunization Strategies Against Pediatric AIDS
针对儿童艾滋病的被动-主动免疫策略
  • 批准号:
    7065729
  • 财政年份:
    2006
  • 资助金额:
    $ 10.46万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了